Lake Street Advisors Group LLC Has $667,000 Stock Holdings in Hims & Hers Health, Inc. (NYSE:HIMS)

Lake Street Advisors Group LLC lessened its holdings in Hims & Hers Health, Inc. (NYSE:HIMS) by 59.0% during the fourth quarter, HoldingsChannel reports. The fund owned 27,598 shares of the company’s stock after selling 39,768 shares during the quarter. Lake Street Advisors Group LLC’s holdings in Hims & Hers Health were worth $667,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Illinois Municipal Retirement Fund bought a new position in shares of Hims & Hers Health during the fourth quarter valued at about $2,608,000. Amalgamated Bank increased its stake in Hims & Hers Health by 751.2% in the 4th quarter. Amalgamated Bank now owns 55,887 shares of the company’s stock valued at $1,351,000 after buying an additional 49,321 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of Hims & Hers Health by 128.7% during the 4th quarter. Bank of New York Mellon Corp now owns 1,244,953 shares of the company’s stock worth $30,103,000 after buying an additional 700,500 shares in the last quarter. South Dakota Investment Council purchased a new position in shares of Hims & Hers Health in the 4th quarter worth approximately $370,000. Finally, Yong Rong HK Asset Management Ltd bought a new position in shares of Hims & Hers Health in the fourth quarter valued at approximately $41,104,000. Institutional investors own 63.52% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on HIMS. Leerink Partners lifted their price objective on shares of Hims & Hers Health from $24.00 to $40.00 and gave the stock a “market perform” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Hims & Hers Health from $23.00 to $27.00 and gave the stock a “hold” rating in a report on Wednesday, November 6th. Canaccord Genuity Group increased their price objective on Hims & Hers Health from $38.00 to $68.00 and gave the company a “buy” rating in a report on Wednesday, February 19th. Citigroup boosted their target price on Hims & Hers Health from $25.00 to $27.00 and gave the company a “sell” rating in a research note on Tuesday. Finally, Morgan Stanley lowered Hims & Hers Health from an “overweight” rating to an “equal weight” rating and lifted their price objective for the stock from $42.00 to $60.00 in a report on Tuesday, February 18th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, Hims & Hers Health currently has an average rating of “Hold” and a consensus price target of $35.71.

Insiders Place Their Bets

In related news, CEO Andrew Dudum sold 33,513 shares of Hims & Hers Health stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $33.38, for a total value of $1,118,663.94. Following the completion of the transaction, the chief executive officer now owns 33,502 shares in the company, valued at approximately $1,118,296.76. The trade was a 50.01 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Michael Chi sold 7,259 shares of the business’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $24.07, for a total transaction of $174,724.13. Following the completion of the transaction, the insider now owns 193,601 shares of the company’s stock, valued at approximately $4,659,976.07. This trade represents a 3.61 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,097,578 shares of company stock valued at $38,080,320 over the last 90 days. 17.71% of the stock is owned by company insiders.

Hims & Hers Health Stock Performance

NYSE:HIMS opened at $41.30 on Friday. The company has a fifty day moving average of $36.19 and a two-hundred day moving average of $26.46. Hims & Hers Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $72.98. The stock has a market capitalization of $9.02 billion, a PE ratio of 93.85 and a beta of 1.35.

Hims & Hers Health (NYSE:HIMS) last posted its earnings results on Monday, February 24th. The company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.02. The company had revenue of $481.14 million for the quarter, compared to the consensus estimate of $494.56 million. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. Research analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current year.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.